Drug Shortage Report for MIDAZOLAM INJECTION USP

Last updated on 2018-07-26 History
Report ID 14497
Drug Identification Number 02382377
Brand name MIDAZOLAM INJECTION USP
Common or Proper name MIDAZOLAM
Company Name PFIZER CANADA ULC
Active Ingredient(s) MIDAZOLAM
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size VIAL/AMPOULE
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-07
Estimated end date
Actual end date 2018-05-24
Shortage status Resolved
Updated date 2018-07-26
Company comments Please note that the following formats are currently available: - MIDAZOLAM 5mg/mL 10x1mL GVL - MIDAZOLAM 5mg/mL 10x2mL GVL
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2018-07-26 French Compare
v18 2018-07-26 English Compare
v17 2018-02-20 French Compare
v16 2018-02-20 English Compare
v15 2018-02-20 French Compare
v14 2018-02-20 English Compare
v13 2017-12-15 French Compare
v12 2017-12-15 English Compare
v11 2017-12-15 French Compare
v10 2017-12-15 English Compare
v9 2017-11-21 French Compare
v8 2017-11-21 English Compare
v7 2017-10-23 French Compare
v6 2017-10-23 English Compare
v5 2017-07-21 English Compare
v4 2017-07-19 French Compare
v3 2017-07-19 English Compare
v2 2017-07-03 French Compare
v1 2017-07-03 English Compare